EUVIMEDEUVIMED entdecken
Crossref

Alloimmunization Against RBC Antigens Is Not Associated With Decreased Survival in Liver Transplant Recipients

Yevgen Chornenkyy iD, Alcino Pires Gama, Christopher Felicelli, Nigar Khurram, Adam L Booth, Joseph R Leventhal, Glenn Eugene Ramsey, Guang-Yu Yang

American Journal of Clinical Pathology · 13.03.2023 · 159 (3) · 255-262

DOI: 10.1093/ajcp/aqac150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 10.01.2023. Verfasst von Yevgen Chornenkyy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, McGaw Medical Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. Hauptthemen laut MEDLINE: Liver Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Northwestern University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Improvement of liver transplantation (LT) outcomes requires better understanding of factors affecting survival. The presence of RBC alloantibodies (RBCAs) on survival in LT recipients was evaluated.

Methods

This study was a single-center, retrospective cohort study reviewing transfusion records and all-cause mortality between 2002 and 2021.

Results

Between 2002 and 2021, 2079 LTs were completed, 1,396 of which met inclusion criteria (1,305 RBCA negative; 91 RBCA positive [6.5%]). The cohorts were similar in age (mean [range], 55.8 [17-79] years vs 56.8 [25-73] years; P = .41, respectively) or sex (RBCA negative, 859 [65%] men and 446 [35%] women vs RBCA positive, 51 [56%] men and 40 [44%] women; P = .0684). Of 132 RBCAs detected, 10 were most common were to E (27.27%), Jka (15.91%), K (9.09%), C (8.33%), M (6.06%), D (5.3%), Fya (4.55%), e (2.27%), c (2.27%), and Jkb (2.27%). Twenty-seven patients (29.7%) had more than 1 RBCA; the most common combinations were C with Jka (7.4%) and E with Dia (7.4%). All-cause mortality was increased in men (men, 14.45 years vs women, 17.27 years; P = .0266) and patients 65 years of age and older (≥65 years of age, 10.21 years vs <64 years of age, 17.22 years; P < .0001). The presence of RBCA (≥1) did not affect all-cause mortality (RBCA negative, 14.17 years vs RBCA positive, 15.29 years; P = .4367). The top 5 causes of death were infection (11.9%), primary malignancy (solid) (10.8%), recurrent malignancy (10.5%), cardiovascular arrest (7.1%), and pulmonary insufficiency/respiratory failure (5.7%).

Conclusions

Survival in RBCA-positive LT recipients is no different from that in RBCA-negative LT recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationMaleHumansFemaleChildAdolescentMiddle AgedRetrospective StudiesNeoplasm Recurrence, LocalErythrocytesBlood TransfusionIsoantibodiesTransplant Recipients

Stichwörter der Autor:innen

RBC transfusionTransfusion practices (surgical)Transplantation—solid organ

Substanzen

Isoantibodies

Autor:innen und Institutionen

  • Department of Pathology, McGaw Medical Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
  • Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Surgery, McGaw Medical Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
  • Comprehensive Transplant Center, McGaw Medical Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

ORCID-Profile: Yevgen Chornenkyy

Förderung

  • Northwestern University

Zitieren

APA

Chornenkyy, Y., Gama, A. P., Felicelli, C., Khurram, N., Booth, A. L., Leventhal, J. R., Ramsey, G. E., & Yang, G. Y. (2023). Alloimmunization Against RBC Antigens Is Not Associated With Decreased Survival in Liver Transplant Recipients. American Journal of Clinical Pathology, 159(3), 255-262. https://doi.org/10.1093/ajcp/aqac150

Vancouver

Chornenkyy Y, Gama AP, Felicelli C, Khurram N, Booth AL, Leventhal JR, et al. Alloimmunization Against RBC Antigens Is Not Associated With Decreased Survival in Liver Transplant Recipients. American Journal of Clinical Pathology. 2023;159(3):255-262. doi:10.1093/ajcp/aqac150

BibTeX
@article{Chornenkyy2023,
  author = {Chornenkyy, Yevgen and Gama, Alcino Pires and Felicelli, Christopher and Khurram, Nigar and Booth, Adam L and Leventhal, Joseph R and Ramsey, Glenn Eugene and Yang, Guang-Yu},
  title = {Alloimmunization Against RBC Antigens Is Not Associated With Decreased Survival in Liver Transplant Recipients},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  volume = {159},
  number = {3},
  pages = {255--262},
  doi = {10.1093/ajcp/aqac150}
}
Kostenlos starten →